News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
144 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (24806)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
FDA
Grifols HyperRAB (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
The most common adverse reactions during clinical trials were injection-site pain and headache.
February 6, 2018
·
8 min read
Business
Valeant Will Release Fourth-Quarter and Full-Year 2017 Financial Results On February 28
Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update.
February 6, 2018
·
1 min read
TTP Labtech Collaborates With Onespacemedia for Website Redevelopment
TTP LabTech Ltd., a global leader in the design and development of automated instrumentation and consumables for life science applications, is delighted to announce the launch of its new website.
February 6, 2018
·
2 min read
Balmes Transplantation Raises €700,000 in Seed Funding
These funds, combined with the 900,000 euros previously raised by the company since its creation, will be used to perform in vivo proof-of-concept studies of Balmes Transplantation’s first molecule combinations.
February 6, 2018
·
5 min read
BioCapital
Gore to Debut GORE ImproJect Plunger for Sensitive Biologics in Pre-Filled Syringes
Gore, will introduce its new GORE ImproJect Plunger at Pharmapack 2018, Europe’s dedicated pharmaceutical packaging and drug delivery event.
February 6, 2018
·
3 min read
Business
Allergan Reports Solid Finish to 2017 With 12% Increase in Fourth Quarter GAAP Net Revenues to $4.3B
Allergan today reported its fourth quarter and full-year 2017 continuing operations performance.
February 6, 2018
·
267 min read
Biotech Bay
CellMax Life Release: Study Presented at ASCO GU 2018 Shows Circulating Tumor Cell Blood Test May Enhance Utility of PSA Screening By Reducing Unnecessary Prostate Biopsies by Up to 90%
These results illustrate the test’s potential to reduce unnecessary prostate biopsies by up to 90 percent.
February 6, 2018
·
5 min read
CompleWare Releases CompleClinical 2.0
CompleWare announces the release of version 2.0 of their flagship eClinical software solution, CompleClinical.
February 6, 2018
·
1 min read
Genetown
Allurion Technologies Commences Landmark Pivotal U.S. Clinical Trial for the Elipse Balloon
Allurion Technologies today announces the start of ENLIGHTEN, a United States clinical trial for the Elipse Balloon – the world’s first and only procedureless™ gastric balloon for weight loss.
February 6, 2018
·
3 min read
Business
Spectralytics Opens Facility Dedicated to New Product Development
Spectralytics announces the opening of a product development center in Maple Plain, Minn. Building upon its reputation of high-quality laser processing solutions for medical device manufacturing,
February 6, 2018
·
3 min read
Previous
3 of 15
Next